| IL6 blockade reprograms the lung tumor microenvironment to limit the development and progression of K-ras–mutant lung cancer MS Caetano, H Zhang, AM Cumpian, L Gong, N Unver, EJ Ostrin, S Daliri, ... Cancer research 76 (11), 3189-3199, 2016 | 195 | 2016 |
| IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets N Unver, F McAllister Cytokine & growth factor reviews 41, 10-17, 2018 | 179 | 2018 |
| IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties N Khosravi, MS Caetano, AM Cumpian, N Unver, C De la Garza Ramos, ... Cancer immunology research 6 (7), 788-797, 2018 | 68 | 2018 |
| Reduced IL‐6 levels and tumor‐associated phospho‐STAT 3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo‐inositol N Unver, O Delgado, K Zeleke, A Cumpian, X Tang, MS Caetano, H Wang, ... International journal of cancer 142 (7), 1405-1417, 2018 | 40 | 2018 |
| CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression: CXCL7-induced macrophage chemotaxis in LLC tumors N Unver, G Esendagli, G Yilmaz, D Guc Cytokine 75 (2), 330-337, 2015 | 31 | 2015 |
| Molecular analysis of Chanarin-Dorfman syndrome (CDS) patients: Identification of novel mutations in the ABHD5 gene S Emre, N Ünver, SE Evans, A Yüzbaşıoğlu, F Gürakan, F Gümrük, ... European Journal of Medical Genetics 53 (3), 141-144, 2010 | 28 | 2010 |
| Macrophage chemoattractants secreted by cancer cells: Sculptors of the tumor microenvironment and another crucial piece of the cancer secretome as a therapeutic target N Unver Cytokine & growth factor reviews 50, 13-18, 2019 | 24 | 2019 |
| SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas I Tanaka, D Dayde, MC Tai, H Mori, LM Solis, SC Tripathi, JF Fahrmann, ... JNCI: Journal of the National Cancer Institute 114 (2), 290-301, 2022 | 20 | 2022 |
| Investigation of hemophagocytic lymphohistiocytosis in severe sepsis patients B Halacli, N Unver, SO Halacli, H Canpinar, EO Ersoy, S Ocal, D Guc, ... Journal of critical care 35, 185-190, 2016 | 17 | 2016 |
| Transcriptional splice variants of CD40 and its prognostic value in breast cancer N Ünver, DY Ermiş, BZ Weber, G Esendağli Turkish Journal of Biology 44 (2), 73-81, 2020 | 10 | 2020 |
| Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools. N Unver Medical Oncology 38, 68, 2021 | 7 | 2021 |
| Regulatory Role of Chemerin in Lung Tumorigenesis and Cancer-associated Inflammation: Anti-inflammatory effect of chemerin in cancer N Unver, G Yilmaz, H Canpinar, D Guc, G Esendagli Acta Medica 49 (1), 2018 | 3 | 2018 |
| Myo-inositol reduces pro-tumoral IL6 inflammation in a mouse model of lung cancer chemoprevention EJ Ostrin, N Unver, O Delgado, M Caetano, K Zeleke, A Cumpian, X Tang, ... C19. MOLECULAR MECHANISMS OF DYSREGULATED INFLAMMATION, PROLIFERATION, AND …, 2017 | 3 | 2017 |
| Cancer stemness as a target for immunotherapy is shaped by pro-inflammatory stress. N Unver Current Stem Cell Research & Therapy, 0 | 3* | |
| Revisiting CCL-type chemokines in breast cancer and its milieu: prominent targetable chemokines, CCL8 and CCL21 N Unver Bioscience reports 41 (7), BSR20210033, 2021 | 2 | 2021 |
| The effects of Cancer Associated Fibroblasts on mechanisms of immune evasion in a rat chemical mammary carcinoma model G Gunaydin, Y Dolen, N Unver, SA Kesikli, D Guc Front Immunol 4 (10.3389), 2013 | 2 | 2013 |
| Mechanisms of Antitumor Immunity and Immunosurveillance C Mohindroo, N Unver Methods and Protocols, 1-6, 2021 | 1 | 2021 |
| Sophisticated genetically engineered macrophages, CAR-Macs, in hitting the bull’s eye for solid cancer immunotherapy approaches N Unver Clinical and Experimental Medicine, 2023 | | 2023 |
| Tailored modulation of stemness and drug resistance marker characteristics in K-Ras mutant lung cancer cells via PD-L1 gene suppression N Unver, E Tavukcuoglu, G Esendagli Life sciences 311, 121171, 2022 | | 2022 |
| Targets and Strategies for Cancer Immunoprevention N Unver, Mohindroo,Chirayu Methods and Protocols, 7-17, 2021 | | 2021 |
